multivalent vaccine (Serenta Biotechnology)

N/A

Report date: 2025/03/20 15:02:12

Base Information

Drug Namemultivalent vaccine (Serenta Biotechnology)
Drug Alias NameMRSA infection vaccine (University of Maryland)
ClassificationVaccines > Application > Prophylactic vaccineDiagnostic agent (In vivo)
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Maryland
China Registration ClassN/A

Develop Information

Active CompaniesSerenta Biotechnology LLC
Inactive CompaniesUM VenturesUniversity Of Maryland
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A